ArticlePediatric research2026
Detecting hidden threats: proteomic changes in urinary extracellular vesicles are associated with pediatric kidney allograft rejection.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly detection of kidney allograft injury is essential to preserve long-term graft function. Current diagnostics, particularly biopsy, are invasive and may be inconclusive. Extracellular-vesicles (EVs) carry molecular cargo that reflects renal cellular states. Although EV proteomics has shown promise for detecting acute rejection (AR) in adults, its value in pediatrics(PKT) is not well defined.
methodsIn this pilot study, urine samples from 29 PKT recipients and 3 healthy controls were analyzed, including 7 with biopsy-confirmed AR, 9 with chronic rejection (CR), and 13 with stable graft function (ST). Classification was based on urine findings, creatinine trends, and biopsy results. EVs were isolated from fresh-second-void urine by ultracentrifugation and analyzed using LC/MS. Longitudinal samples from three AR patients assessed temporal proteomic changes.
resultsOverall, 192 proteins were differentially abundant across groups (FDR p < 0.05). AR showed enrichment of immune-related pathways and increased free hemoglobin proteins compared with ST, while CR closely resembled ST. EV concentration and size distribution were similar across groups, indicating proteomic differences were independent of EV abundance. Longitudinal analyses revealed dynamic proteomic changes corresponding to rejection and recovery.
conclusionsEV proteomics is a promising approach for detecting and monitoring AR in PKT recipients and warrants larger multicenter studies. IMPACT: This pilot study demonstrates urinary extracellular vesicle (EV) proteomics as a promising non-invasive approach to detect and monitor acute rejection (AR) in pediatric kidney-transplant (PKT) recipients. EVs carry molecular cargo reflecting kidney cell states, providing a dynamic readout of graft health and injury. Early identification of rejection may reduce reliance on invasive biopsies, enable timely intervention, and support precision-based, personalized management. As the first study to characterize EV proteomic profiles in PKT, it lays important groundwork. Larger multicenter studies are warranted to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.